| Autor: |
Zuardi AW; Departamento de Neurociências e Ciências do Comportamento, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil. Medicina Translacional, Instituto Nacional de Ciência e Tecnologia (INCT), Ribeirão Preto, SP, Brazil., Crippa JA; Departamento de Neurociências e Ciências do Comportamento, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil. Medicina Translacional, Instituto Nacional de Ciência e Tecnologia (INCT), Ribeirão Preto, SP, Brazil. |
| Jazyk: |
angličtina |
| Zdroj: |
Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) [Braz J Psychiatry] 2023 Nov-Dec; Vol. 45 (6), pp. 463-464. Date of Electronic Publication: 2023 Nov 25. |
| DOI: |
10.47626/1516-4446-2023-3377 |
| Abstrakt: |
Competing Interests: AWZ is a co-owner of a patent for fluorinated CBD compounds (licensed to Phytecs) and has a patent pending for a cannabinoid-containing oral pharmaceutical composition outside the submitted work. JAC was a consultant and/or has received speaker fees and/or sits on the advisory board and/or receives research funding and/or receives speaker fees from Janssen-Cilag, Torrent Pharm, Ease Labs Pharm, Prati-Donaduzzi, Mantecorp, ArtMed, PurMed Global, and BSPG Pharm over the past 3 years. JAC is the coinventor of the patent ''Fluorinated CBD compounds, compositions, and uses thereof, Pub. No.: WO/2014/108899, International Application No.: PCT/IL2014/050023,'' Def. US number Reg. 62193296; July 29, 2015; INPI on August 19, 2015 (BR1120150 164927; Mechoulam R, Zuardi AW, Kapczinski F, Hallak JEC, Guimarães FS, Crippa JAS, Breuer A). Universidade de São Paulo (USP) has licensed this patent to Phytecs Pharm (USP Resolution No. 15.1.130002.1.1). It has an agreement with Prati-Donaduzzi to ''develop a pharmaceutical product containing synthetic CBD and prove its safety and therapeutic efficacy in the treatment of epilepsy, schizophrenia, Parkinson's disease, and anxiety disorders.'' JAC is the coinventor of the patent ''Cannabinoid-containing oral pharmaceutical composition, method for preparing and using the same,'' INPI on September 16, 2016 (BR 112018005423-2). |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
